Literature DB >> 16678005

Drug-associated renal dysfunction.

Stephanie S Taber1, Bruce A Mueller.   

Abstract

Acute renal failure (ARF) in patients in the ICU is associated with a high mortality. Drug-induced renal dysfunction is an important, yet often overlooked, cause of ARF in this patient population. A drug use evaluation at the authors' institution, to assess the prescribing patterns of potential nephrotoxins in the adult and pediatric ICUs, found that antibiotics (aminoglycosides, amphotericin B, penicillins, cephalosporins, acyclovir), nonsteroidal anti-inflammatory drugs, contrast dye, and various other nephrotoxic medications are used widely in all of the ICUs. By focusing on several commonly prescribed classes of nephrotoxic medications in the ICU, this article reviews the general mechanisms of drug-associated renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678005     DOI: 10.1016/j.ccc.2006.02.003

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  23 in total

Review 1.  Drug-induced acute kidney injury in children.

Authors:  Lauren N Faught; Michael J E Greff; Michael J Rieder; Gideon Koren
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  Development of inpatient risk stratification models of acute kidney injury for use in electronic health records.

Authors:  Michael E Matheny; Randolph A Miller; T Alp Ikizler; Lemuel R Waitman; Joshua C Denny; Jonathan S Schildcrout; Robert S Dittus; Josh F Peterson
Journal:  Med Decis Making       Date:  2010-03-30       Impact factor: 2.583

Review 3.  Use of transcriptomics in understanding mechanisms of drug-induced toxicity.

Authors:  Yuxia Cui; Richard S Paules
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

4.  National Veterans Health Administration inpatient risk stratification models for hospital-acquired acute kidney injury.

Authors:  Robert M Cronin; Jacob P VanHouten; Edward D Siew; Svetlana K Eden; Stephan D Fihn; Christopher D Nielson; Josh F Peterson; Clifton R Baker; T Alp Ikizler; Theodore Speroff; Michael E Matheny
Journal:  J Am Med Inform Assoc       Date:  2015-06-23       Impact factor: 4.497

Review 5.  Paradigms of acute kidney injury in the intensive care setting.

Authors:  John A Kellum; John R Prowle
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

6.  Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Aviva Goldberg; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2008-07-16       Impact factor: 1.880

Review 7.  Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.

Authors:  Alexandre Boyer; Didier Gruson; Stéphane Bouchet; Benjamin Clouzeau; Bui Hoang-Nam; Frédéric Vargas; Hilbert Gilles; Mathieu Molimard; Anne-Marie Rogues; Nicholas Moore
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

8.  Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.

Authors:  W Picard; F Bazin; B Clouzeau; H-N Bui; M Soulat; E Guilhon; F Vargas; G Hilbert; S Bouchet; D Gruson; N Moore; A Boyer
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

Review 9.  Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery.

Authors:  T P Barros; W K Alderton; H M Reynolds; A G Roach; S Berghmans
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

10.  A child presenting with acute renal failure secondary to a high dose of indomethacin: a case report.

Authors:  Felipe González; Jesús López-Herce; Cinta Moraleda
Journal:  J Med Case Rep       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.